The FDA has approved a new weight loss pill, specifically a GLP-1 medication called Foundayo from Eli Lilly, in a speedy process. However, it is unclear what was lost at the FDA, as some reports focus on the approval of the weight loss pill, while others mention the agency losing staff members. The approval of the weight loss pill has been widely reported, but the context of what was lost at the FDA remains unclear.